Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study

Table 3

Skin-rash incidence.

	All grades (, %)	Grade 1 (, %)	Grade 2 (, %)	Grade 3 (, %)
Skin rash	14 (41.2)	7 (20.6)	7 (20.6)	0
Female	8 (23.5)	2 (5.9)	3 (8.6)	0
Male	6 (17.6)	5 (14.7)	4 (12)	0